Olga Goloubeva

9.8k total citations · 2 hit papers
146 papers, 6.7k citations indexed

About

Olga Goloubeva is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Olga Goloubeva has authored 146 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Oncology, 32 papers in Molecular Biology and 25 papers in Hematology. Recurrent topics in Olga Goloubeva's work include Head and Neck Cancer Studies (23 papers), Estrogen and related hormone effects (19 papers) and Multiple Myeloma Research and Treatments (18 papers). Olga Goloubeva is often cited by papers focused on Head and Neck Cancer Studies (23 papers), Estrogen and related hormone effects (19 papers) and Multiple Myeloma Research and Treatments (18 papers). Olga Goloubeva collaborates with scholars based in United States, Italy and Russia. Olga Goloubeva's co-authors include Ashraf Badros, Kevin J. Cullen, Amy M. Fulton, Nicholas J. Sarlis, Robert I. Haddad, Marshall R. Posner, Jochen H. Lorch, Aaron P. Rapoport, Xinrong Ma and Namita Kundu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Olga Goloubeva

142 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial

2011 353 citations Marshall R. Posner, Jochen H. Lorch et al. profile →
Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial

2011 310 citations Jochen H. Lorch, Olga Goloubeva et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Olga Goloubeva United States	44	2.5k	1.8k	973	945	941	146	6.7k
Gaetano De Rosa Italy	46	3.0k 1.2×	2.7k 1.5×	378 0.4×	1.4k 1.5×	1.4k 1.5×	349	8.9k
Efstratios Patsouris Greece	49	2.5k 1.0×	3.2k 1.8×	233 0.2×	1.1k 1.2×	1.6k 1.7×	385	9.0k
Caj Haglund Finland	54	4.6k 1.8×	3.9k 2.2×	536 0.6×	1.6k 1.7×	2.4k 2.5×	363	11.5k
Edmond Sabo Israel	52	2.1k 0.8×	2.6k 1.5×	168 0.2×	1.7k 1.8×	2.0k 2.1×	267	9.2k
Hideo Yoshida Japan	47	1.9k 0.7×	2.3k 1.3×	134 0.1×	858 0.9×	1.6k 1.7×	360	8.8k
Roger Henriksson Sweden	52	3.5k 1.4×	4.8k 2.7×	374 0.4×	3.7k 3.9×	1.2k 1.2×	405	14.7k
Gerardo Botti Italy	60	6.7k 2.6×	5.2k 3.0×	277 0.3×	2.2k 2.3×	2.0k 2.1×	541	14.9k
J. Stuart United Kingdom	44	929 0.4×	809 0.5×	213 0.2×	1.2k 1.3×	316 0.3×	200	7.0k
Franky Leung Chan Hong Kong	43	992 0.4×	2.4k 1.3×	204 0.2×	1.3k 1.4×	1.2k 1.3×	223	6.2k
Jae‐Weon Kim South Korea	60	3.1k 1.2×	3.7k 2.1×	109 0.1×	1.1k 1.2×	2.2k 2.4×	597	14.5k

Countries citing papers authored by Olga Goloubeva

Since Specialization

Citations

This map shows the geographic impact of Olga Goloubeva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Goloubeva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Goloubeva more than expected).

Fields of papers citing papers by Olga Goloubeva

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Goloubeva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Goloubeva. The network helps show where Olga Goloubeva may publish in the future.

Co-authorship network of co-authors of Olga Goloubeva

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Goloubeva. A scholar is included among the top collaborators of Olga Goloubeva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Goloubeva. Olga Goloubeva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, David, Olga Goloubeva, Aaron P. Rapoport, et al.. (2025). CD19 CAR-T With Axicabtagene Ciloleucel in R/R Large B-Cell Lymphoma With/Without Prior Autologous Stem Cell Transplant. Clinical Lymphoma Myeloma & Leukemia. 25(6). 432–439. 1 indexed citations

Goloubeva, Olga, James F. Childress, Grace Li, et al.. (2024). Clinical outcomes of patients with acute myeloid leukemia and cardiovascular disease. Leukemia Research. 138. 107456–107456. 2 indexed citations

Amr, Sania, et al.. (2021). Treatment modalities, adverse events, and survival outcomes in older patients with head and neck squamous cell carcinoma. Head & Neck. 43(12). 3935–3945. 4 indexed citations

McCusker, Michael G., Ranee Mehra, Sania Amr, et al.. (2021). Comparison of efficacy and toxicity of chemoradiation regimens for head and neck squamous cell carcinoma primary treatment. Head & Neck. 44(3). 749–759. 3 indexed citations

Burrowes, Shana, Olga Goloubeva, Kristen A. Stafford, et al.. (2021). Enhanced mindfulness-based stress reduction in episodic migraine—effects on sleep quality, anxiety, stress, and depression: a secondary analysis of a randomized clinical trial. Pain. 163(3). 436–444. 25 indexed citations

Seminowicz, David A., Shana Burrowes, Jing Zhang, et al.. (2020). Enhanced mindfulness-based stress reduction in episodic migraine: a randomized clinical trial with magnetic resonance imaging outcomes. Pain. 161(8). 1837–1846. 68 indexed citations

Goloubeva, Olga, James F. Childress, Vu H. Duong, et al.. (2020). Impact of Cardiovascular Disease on Clinical Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome. Blood. 136(Supplement 1). 37–38. 1 indexed citations

Wadajkar, Aniket S., Nina P. Connolly, Rebeca Galisteo, et al.. (2020). Decreased nonspecific adhesivity, receptor-targeted therapeutic nanoparticles for primary and metastatic breast cancer. Science Advances. 6(3). eaax3931–eaax3931. 60 indexed citations

Badros, Ashraf, Elizabeth Hyjek, Ning Ma, et al.. (2017). Pembrolizumab, pomalidomide, and low-dose dexamethasone for relapsed/refractory multiple myeloma. Blood. 130(10). 1189–1197. 146 indexed citations

10.

Holtzman, Noa G., Olga Goloubeva, Zeba N. Singh, et al.. (2017). Plasma Cell Leukemia (PCL): Clinical Characteristics, Outcomes, and the Impact of Circulating Plasma Cells (CPC) Percentage — A Single Center Experience. Blood. 130. 3035–3035.

11.

Dell, Cameron, Olga Goloubeva, Aaron P. Rapoport, et al.. (2017). Similar Survival for African American and Caucasian Multiple Myeloma Patients Receiving Auto-SCT. Blood. 130. 2177–2177. 1 indexed citations

12.

Jung, Seungyoun, Olga Goloubeva, Catherine Klifa, et al.. (2016). Dietary Fat Intake During Adolescence and Breast Density Among Young Women. Cancer Epidemiology Biomarkers & Prevention. 25(6). 918–926. 12 indexed citations

13.

Boggs, Amanda E., Michele Vítolo, Rebecca A. Whipple, et al.. (2014). α-Tubulin Acetylation Elevated in Metastatic and Basal-like Breast Cancer Cells Promotes Microtentacle Formation, Adhesion, and Invasive Migration. Cancer Research. 75(1). 203–215. 152 indexed citations

14.

Zandberg, Dan P., Sandy Liu, Olga Goloubeva, Lisa M. Schumaker, & Kevin J. Cullen. (2014). Emergence of HPV16-Positive Oropharyngeal Cancer in Black Patients Over Time: University of Maryland 1992–2007. Cancer Prevention Research. 8(1). 12–19. 25 indexed citations

15.

Sabnis, Gauri, Olga Goloubeva, Armina A. Kazi, Preeti Shah, & Angela Brodie. (2013). HDAC Inhibitor Entinostat Restores Responsiveness of Letrozole-Resistant MCF-7Ca Xenografts to Aromatase Inhibitors through Modulation of Her-2. Molecular Cancer Therapeutics. 12(12). 2804–2816. 53 indexed citations

16.

Bhalla, Kavita, Bor Jang Hwang, Ruby E. Dewi, et al.. (2012). Metformin Prevents Liver Tumorigenesis by Inhibiting Pathways Driving Hepatic Lipogenesis. Cancer Prevention Research. 5(4). 544–552. 123 indexed citations

17.

Ma, Xinrong, Kelly J. Norsworthy, Namita Kundu, et al.. (2009). CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model. Molecular Cancer Therapeutics. 8(3). 490–498. 124 indexed citations

18.

Posner, Marshall R., Lisa M. Schumaker, Ming Tan, et al.. (2009). Racial Survival Disparity in Head and Neck Cancer Results from Low Prevalence of Human Papillomavirus Infection in Black Oropharyngeal Cancer Patients. Cancer Prevention Research. 2(9). 776–781. 221 indexed citations

19.

Goloubeva, Olga, Mirko Loghi, Massimo Poncino, & Enrico Macii. (2007). Architectural leakage-aware management of partitioned scratchpad memories. Design, Automation, and Test in Europe. 1665–1670. 12 indexed citations

20.

Goloubeva, Olga, M. Sonza Reorda, & M. Violante. (2004). Automatic generation of validation stimuli for application-specific processors. Design, Automation, and Test in Europe. 1. 10188–10188. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact